This book provides the reader with a focused review of multimodality imaging strategies (radiology and molecular imaging) in staging and re-staging the major types of cancer (i.e. thyroid, breast, colon-rectum, lung, prostate, pancreas, liver, head and neck, and hematological cancer), including rare neoplasms.
In addition to presenting the possible diagnostic pathways for all oncologic diseases, the book identifies those interventions currently available in clinical practice (these being a branch of interventional radiology), while also examining and detailing molecular radiotherapy strategies.
The work has an interdisciplinary appeal and, thanks to its highly informative and cutting-edge coverage, professionals as well as advanced students and residents in radiology, oncology and surgery will find it of particular interest.
About the Author: Emanuele Neri is Full Professor of Radiology, Head of the Academic Unit of Radiology at Pisa University Hospital, Director of the Post-graduate School of Radiology, and Chair of the University Master in Oncologic Imaging, at the University of Pisa,
Further, he is President of the European Society of Oncologic Imaging, and President of the Tuscany Chapter of the Italian Society of Medical and Interventional Radiology
He has spent the majority of his clinical and scientific career in the field of oncologic imaging, with a specific focus on colorectal and head & neck cancer, with special interest on the applications of structured reporting and artificial intelligence.
Paola Anna Erba, MD, PhD, Prof. Paola Anna Erba is Associated professor in Nuclear Medicine and Diagnostic Imaging at the Medical Faculty of Bicocca University, Chair of the Nuclear Medicine department of the ASST Papa Giovanni XXIII in Bergamo. She is also affiliated with the Department of Nuclear Medicine and Molecular Imaging at the University Medical Center Groningen, the Netherlands.
She is the President Elect 2023-2025 of the European Association of Nuclear Medicine (EANM).
Her research interest broadly covers the infection and inflammation field as well as oncology. Her main area of interest are cardiovascular infections a field where her work has resulted into the introduction of multimodality imaging in the clinical guideline in infectious endocarditis and CIEDs infections. In oncology, her research area is represented by the validation of new targets/probes for radioimmunoscintigraphy/radioimmuno PET and radioimmunotherapy also by conduction translational-early phase in human clinical study.
